Fundraising FoxEndevica Bio
1 known investors
Find your way into Endevica Bio
Sign up to see every warm intro you have to Endevica Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Endevica Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Endevica (Kalohexis) is a clinical-stage biotechnology company developing peptidomimetic melanocortin drug candidates. Its pipeline targets metabolic disorders such as obesity and cancer cachexia.
Investors · 1
Frequently asked questions
- What does Endevica Bio do?
- Endevica (Kalohexis) is a clinical-stage biotechnology company developing peptidomimetic melanocortin drug candidates. Its pipeline targets metabolic disorders such as obesity and cancer cachexia.
- Who are Endevica Bio's investors?
- Endevica Bio's investors include Centennial Investors.